IN8BIO, INC. Finance Lease, Principal Payments
IN8BIO, INC. (INAB) reported Finance Lease, Principal Payments of $169.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:FinanceLeasePrincipalPayments · last filed 2026-08-06
- IN8BIO, INC. finance lease, principal payments for the quarter ending 2026-06-30 was $62.00K, a 73.50% decline year-over-year.
- IN8BIO, INC. finance lease, principal payments for the quarter ending 2026-03-31 was $107.00K, a 52.44% decline year-over-year.
- IN8BIO, INC. finance lease, principal payments for the quarter ending 2025-12-31 was $111.00K, a 49.32% decline year-over-year.
- IN8BIO, INC. finance lease, principal payments for the quarter ending 2025-09-30 was $123.00K, a 42.25% decline year-over-year.
- IN8BIO, INC. finance lease, principal payments for fiscal 2025 was $693.00K, a 12.72% decline from fiscal 2024.
- IN8BIO, INC. finance lease, principal payments for fiscal 2024 was $794.00K, a 0.50% decline from fiscal 2023.
- IN8BIO, INC. finance lease, principal payments for fiscal 2023 was $798.00K, a 29.76% increase from fiscal 2022.
- IN8BIO, INC. finance lease, principal payments for fiscal 2022 was $615.00K, a 14.95% increase from fiscal 2021.
| Period end | Finance Lease, Principal Payments 3 month | Finance Lease, Principal Payments 6 month | Finance Lease, Principal Payments 9 month | Finance Lease, Principal Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $62.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $169.00K 10-Q · filed 2026-08-06 | $280.00K derived: sum of 3 quarters · filed 2026-08-06 | $403.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $107.00K 10-Q · filed 2026-05-07 | $218.00K derived: sum of 2 quarters · filed 2026-05-07 | $341.00K derived: sum of 3 quarters · filed 2026-05-07 | $575.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $234.00K derived: sum of 2 quarters · filed 2026-03-12 | $468.00K derived: sum of 3 quarters · filed 2026-08-06 | $693.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $123.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $357.00K derived: sum of 2 quarters · filed 2026-08-06 | $582.00K 10-Q · filed 2025-11-06 | $801.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $234.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $459.00K 10-Q · filed 2026-08-06 | $678.00K derived: sum of 3 quarters · filed 2026-08-06 | $891.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $225.00K 10-Q · filed 2026-05-07 | $444.00K derived: sum of 2 quarters · filed 2026-05-07 | $657.00K derived: sum of 3 quarters · filed 2026-05-07 | $831.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $219.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $432.00K derived: sum of 2 quarters · filed 2026-03-12 | $606.00K derived: sum of 3 quarters · filed 2026-03-12 | $794.00K 10-K · filed 2026-03-12 |
| 2024-09-30 | $213.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $387.00K derived: sum of 2 quarters · filed 2025-11-06 | $575.00K 10-Q · filed 2025-11-06 | $748.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $174.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $362.00K 10-Q · filed 2025-08-07 | $535.00K derived: sum of 3 quarters · filed 2025-08-07 | $771.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $188.00K 10-Q · filed 2025-05-07 | $361.00K derived: sum of 2 quarters · filed 2025-05-07 | $597.00K derived: sum of 3 quarters · filed 2025-05-07 | $811.00K derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | $173.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $409.00K derived: sum of 2 quarters · filed 2025-03-13 | $623.00K derived: sum of 3 quarters · filed 2025-03-13 | $798.00K 10-K · filed 2025-03-13 |
| 2023-09-30 | $236.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $450.00K derived: sum of 2 quarters · filed 2024-11-12 | $625.00K 10-Q · filed 2024-11-12 | $922.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $214.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $389.00K 10-Q · filed 2024-08-08 | $686.00K derived: sum of 3 quarters · filed 2024-08-08 | $774.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $175.00K 10-Q · filed 2024-05-09 | $472.00K derived: sum of 2 quarters · filed 2024-05-09 | $560.00K derived: sum of 3 quarters · filed 2024-05-09 | $655.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $297.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $385.00K derived: sum of 2 quarters · filed 2024-03-14 | $480.00K derived: sum of 3 quarters · filed 2024-03-14 | $615.00K 10-K · filed 2024-03-14 |
| 2022-09-30 | $88.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $183.00K derived: sum of 2 quarters · filed 2023-11-09 | $318.00K 10-Q · filed 2023-11-09 | $463.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $95.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $230.00K 10-Q · filed 2023-08-10 | $375.00K derived: sum of 3 quarters · filed 2023-08-10 | $517.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $135.00K 10-Q · filed 2023-05-12 | $280.00K derived: sum of 2 quarters · filed 2023-05-12 | $422.00K derived: sum of 3 quarters · filed 2023-05-12 | $558.00K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $145.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $287.00K derived: sum of 2 quarters · filed 2023-03-30 | $423.00K derived: sum of 3 quarters · filed 2023-03-30 | $535.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $142.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $278.00K derived: sum of 2 quarters · filed 2022-11-10 | $390.00K 10-Q · filed 2022-11-10 | $390.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $136.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $248.00K 10-Q · filed 2022-08-12 | $248.00K derived: sum of 3 quarters · filed 2022-08-12 | $248.00K derived: sum of 4 quarters · filed 2022-08-12 |
| 2021-03-31 | $112.00K 10-Q · filed 2022-05-12 | $112.00K derived: sum of 2 quarters · filed 2022-05-12 | $112.00K derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $0.00 derived: sum of 2 quarters · filed 2022-03-17 | $0.00 10-K · filed 2022-03-17 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-09-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B |